Baxalta: A Rare Undervalued Biopharmaceutical Company
July 23, 2015 at 08:43 AM EDT
Baxalta may be new, but it is no start-up company. Baxalta has estimated annual revenues of around $6 billion, and 16,000 employees.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |